Abiopharma

📋 Deborah Ann Miller (Officer) plans to sell 4K shares of NUVALENT, INC. (at $97.32 each, total $425K) Filed: Jan 05, 2026 | ID: 003154

📋 Christopher Durant Turner (Officer) plans to sell 4K shares of NUVALENT, INC. (at $97.32 each, total $412K) Filed: Jan 05, 2026 | ID: 003151

📋 Alexandra Balcom (Officer) plans to sell 4K shares of NUVALENT, INC. (at $97.32 each, total $412K) Filed: Jan 05, 2026 | ID: 003150

📋 James Richard Porter (Officer) plans to sell 18K shares of NUVALENT, INC. (at $97.32 each, total $1.7M) Filed: Jan 05, 2026 | ID: 003149

Director FOSTER STEVEN M 🟡 adjusted position in 0 shares (1 derivative) of Tenon Medical, Inc. (TNON) Transaction Date: Jan 01, 2026 | Filing ID: 001474

Director Hochschuler Stephen 🟡 adjusted position in 3.3K shares (1 derivative) of Tenon Medical, Inc. (TNON) at $0.93 Transaction Date: Jan 01, 2026 | Filing ID: 001473

Prince Joshua S. 🟢 acquired 4.4K shares of Vistagen Therapeutics, Inc. (VTGN) at $0.56 Transaction Date: Dec 31, 2025 | Filing ID: 000002

Director WEIGLE ROBERT K 🟡 adjusted position in 3.4K shares (1 derivative) of Tenon Medical, Inc. (TNON) at $0.93 Transaction Date: Jan 01, 2026 | Filing ID: 001472

Director GINN RICHARD 🟡 adjusted position in 47.4K shares (1 derivative) of Tenon Medical, Inc. (TNON) at $0.93 Transaction Date: Jan 01, 2026 | Filing ID: 001471

Director Ferrari Richard 🟡 adjusted position in 1 shares (1 derivative) of Tenon Medical, Inc. (TNON) Transaction Date: Jan 01, 2026 | Filing ID: 001470

Director Jacques Kristine M 🟡 adjusted position in 0 shares (2 derivative) of Tenon Medical, Inc. (TNON) Transaction Date: Jan 01, 2026 | Filing ID: 001469

Director Williamson Kevin 🟡 adjusted position in 18.5K shares (1 derivative) of Tenon Medical, Inc. (TNON) at $0.93 Transaction Date: Jan 01, 2026 | Filing ID: 001468

Director HOWARD IVAN 🟡 adjusted position in 3.3K shares (1 derivative) of Tenon Medical, Inc. (TNON) at $0.93 Transaction Date: Jan 01, 2026 | Filing ID: 001467

New Form SCHEDULE 13G/A - Zentalis Pharmaceuticals, Inc. Filed: 2026-01-05 AccNo: 0001213900-26-001456 Size: 11 KB

ZANTE GREG 🟡 adjusted position in 106.4K shares (1 derivative) of Viking Therapeutics, Inc. (VKTX) at $35.42 ($5.1M) Transaction Date: Jan 02, 2026 | Filing ID: 003116